Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23099009 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
Condition: Neurofibromatosis
Intervention: Drug: Gleevec

Indicates status has not been verified in more than two years